Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Breast 7 Thoracic 6 Lymphoid 4 Genitourinary 4 Other solid neoplasm 3 Other hematologic neoplasm 2 Other 2 Plasma cell 1 Other neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1

Conditions

Melanoma 1 Carcinoma, Merkel Cell 1

Interventions

Blood Specimen Collection 16 Cyclophosphamide 11 fludarabine phosphate 10 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 Photochemotherapy 9 Biopsy 9 Whole-Body Irradiation 8 Standard of Care 8 Radiotherapy 8 Educational Status 8 Surgical Procedures, Operative 7 Radiosurgery 7 Mycophenolic Acid 7 Early Intervention, Educational 7 Aminolevulinic Acid 7 Tomography, Optical Coherence 6 Surveys and Questionnaires 6 Psychiatric Rehabilitation 6 Practice Guidelines as Topic 6 Methods 6 Melphalan 6 Filgrastim 6 Busulfan 5 Antilymphocyte Serum 5 methyl 5-aminolevulinate 4 Therapeutics 4 Sentinel Lymph Node Biopsy 4 Mohs Surgery 4 Microscopy, Confocal 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Exercise Test × Dermatologic × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡